A new approach to help children with leukemia take their medication regularly
MedSupport: A Novel Multilevel Intervention to Identify and Address Barriers to Pediatric Medication
This study is looking to help families of children with Acute Lymphoblastic Leukemia (ALL) make it easier to stick to their chemotherapy at home by testing a new support program, and it involves 150 families from different pediatric cancer centers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-11056818 on NIH RePORTER |
What this research studies
This research focuses on improving medication adherence among children diagnosed with Acute Lymphoblastic Leukemia (ALL) by addressing the barriers that families face in administering chemotherapy at home. The MedSupport intervention will be tested in a clinical trial involving 150 families across eight pediatric cancer programs. Families will be randomly assigned to either receive the MedSupport intervention or standard education on medication adherence. The study will utilize electronic monitoring and biomarkers to accurately measure how well children are following their medication regimen.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are undergoing home-based chemotherapy for Acute Lymphoblastic Leukemia.
Not a fit: Patients who are not undergoing chemotherapy or are older than 11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence in pediatric cancer patients, leading to better health outcomes and reduced hospitalizations.
How similar studies have performed: Previous research has shown that interventions targeting medication adherence can be effective, suggesting that this approach may yield positive results as well.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Bouchard, Elizabeth — Roswell Park Cancer Institute Corp
- Study coordinator: Bouchard, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.